Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 91
Selected: 0
NCT IDTitle
NCT03888066Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
NCT03010072The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum
NCT05786469Patiromer Trial in CKD Stage IIIB to V
NCT01131624Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
NCT04903717Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists
NCT01245777Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy
NCT01324128A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients
NCT01130597Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease
NCT01101399Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy
NCT06434025IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
NCT02232906Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
NCT01820949Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients
NCT03957187Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation
NCT01438359A Drug-Drug Interaction Study of Furosemide and PA21
NCT03087058Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
NCT02688764A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia
NCT01975272The Use of Iron Therapy for Patients With Anemia After Caesarean Section
NCT02033317An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis
NCT05751772Improving Knowledge in Heart Failure Inpatient With Therapeutic Education
NCT03759964Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery
NCT02213653Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
NCT01219309Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents
NCT00821717EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure
NCT00810004Maintenance Treatment of Iron Deficiency in IBD Patients
NCT05885763Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis
NCT01913808Comparing Intravenous and Oral Iron in Postoperative Anemia
NCT01394562Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
NCT05077436Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects
NCT01464190A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
NCT01810939A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)
NCT00994318Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
NCT02147795The German Patient Blood Management Network
NCT03769441Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation
NCT04806048Feasibility of Implementation of Recommended Standards in Patients With Heart Failure
NCT01452906A Drug-Drug Interaction Study of Omeprazole and PA21
NCT03214627Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial
NCT02846896The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
NCT00810030FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
NCT04249648Hyperkalaemia and Its Impact on Therapy with RAASi
NCT05460234RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients
NCT02687594Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)
NCT05514951Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
NCT00706667Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery
NCT01324752A Drug-Drug Interaction Study of Losartan and PA21
NCT01288651Iron Deficiency In Pulmonary Hypertension
NCT01100879Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
NCT03591406To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia
NCT00520780Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)
NCT05625542Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients
NCT01477424A Drug-Drug Interaction Study of Warfarin and PA21